Transforming growth factor β (TGF-β) levels in the conditioned media of human bone cells: relationship to donor age, bone volume, and concentration of TGF-β in human bone matrix in vivo
- 1 June 1999
- Vol. 24 (6) , 565-569
- https://doi.org/10.1016/s8756-3282(99)00082-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal womenBone, 1997
- Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.The Journal of cell biology, 1996
- Systemic administration of transforming growth factor-beta 2 prevents the impaired bone formation and osteopenia induced by unloading in rats.Journal of Clinical Investigation, 1995
- Role of active and latent transforming growth factor β in bone formationJournal of Cellular Biochemistry, 1994
- In vivo induction of bone by recombinant human transforming growth factor β1Journal of Bone and Mineral Research, 1991
- In vivo effects of human recombinant transforming growth factor β on bone turnover in normal miceJournal of Bone and Mineral Research, 1990
- Stimulation of bone formation in vivo by transforming growth factor-β: Remodeling of woven bone and lack of inhibition by indomethacinBone, 1990
- In VivoStimulation of Bone Formation by Transforming Growth Factor-βEndocrinology, 1989
- Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures.Proceedings of the National Academy of Sciences, 1988
- Effects of Transforming Growth Factor-β on Osteoblastic Osteosarcoma Cells*Endocrinology, 1987